EXELIXIS, INC.EXEL

Market cap
$11.6B
P/E ratio
Dec 31,
2011
Dec 31,
2012
Dec 29,
2017
Dec 28,
2018
Jan 3,
2020
Jan 1,
2021
Dec 31,
2021
Dec 30,
2022
Dec 29,
2023
Jan 3,
2025
Net income76-148154690321112231182208521
Depreciation and amortization76158914212629
Impairment of long-lived assets0-0-------64
Stock-based compensation12924415710512010810694
Noncash Lease Expense----355182927
Deferred taxes---244-71-15-476013359
Acquired in-process research and development technology--------12951
Other, net-5-5-22-0-3-2311714
Trade receivable, net---85-4442122-672328
Inventory--33622131213-5
Prepaid expenses and other assets-11233626402830-31
Accrued collaboration liabilities------70-631-0
Accounts payable and other liabilities--314451552653-22
Net cash provided by operating activities-159-123166416527209401363333700
Purchases of marketable securities237533-------928
Proceeds from Sale and Maturity of Marketable Securities125311-------877
Purchases of property, equipment and other, net132133133064284028
Acquired in-process research and development technology-------11112338
Net cash used in investing activities-51-25936-298-587-131-43-524-27-117
Payments for repurchases of common stock--------550652
Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised----222524243362
Taxes paid related to net share settlement of equity awards--78105039232939
Net cash provided by (used in) financing activities188478-1701013-25-151-546-629
Net decrease in cash and cash equivalents---128-4853343-161-240-46
Cash paid for taxes---118413128186170
Right-of-use assets obtained in exchange for lease obligations-----451561715
Operating Lease, Impairment Loss---------60
Liabilities Assumed------4--20